Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
28.98
+1.74 (6.39%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Travere Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,673 | 3,419 | 1,516 | 676 | 1,350 | 1,900 | |
| Market Cap Growth | 45.25% | 125.49% | 124.43% | -49.94% | -28.99% | 36.59% | |
| Enterprise Value | 2,679 | 3,494 | 1,641 | 446 | 1,251 | 1,609 | |
| Last Close Price | 28.98 | 38.21 | 17.42 | 8.99 | 21.03 | 31.04 | |
| Forward PE | 18.26 | 38.08 | - | - | - | - | |
| PS Ratio | 5.45 | 6.97 | 6.50 | 4.65 | 12.33 | 14.42 | |
| PB Ratio | 22.95 | 29.77 | 25.66 | 3.36 | 31.49 | 6.29 | |
| P/TBV Ratio | 2784.54 | 3561.19 | - | 7.01 | - | 12.37 | |
| P/FCF Ratio | 70.75 | 90.48 | - | - | - | - | |
| P/OCF Ratio | 70.75 | 90.48 | - | - | - | - | |
| EV/Sales Ratio | 5.46 | 7.12 | 7.04 | 3.07 | 11.43 | 12.21 | |
| EV/FCF Ratio | 70.91 | 92.47 | - | - | - | - | |
| Debt / Equity Ratio | 2.86 | 2.86 | 6.80 | 2.02 | 9.51 | 0.87 | |
| Debt / EBITDA Ratio | 141.76 | 141.76 | - | - | - | - | |
| Debt / FCF Ratio | 8.70 | 8.70 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.05 | 0.05 | 0.52 | -0.81 | -1.00 | -0.96 | |
| Net Debt / EBITDA Ratio | -2.85 | -2.85 | -0.14 | 0.48 | 0.14 | 1.56 | |
| Net Debt / FCF Ratio | 0.16 | 0.16 | -0.13 | 0.58 | 0.23 | 14.62 | |
| Asset Turnover | 0.82 | 0.82 | 0.34 | 0.20 | 0.15 | 0.19 | |
| Inventory Turnover | 35.83 | 35.83 | 28.86 | 36.81 | 39.16 | 27.48 | |
| Quick Ratio | 2.53 | 2.53 | 1.99 | 3.33 | 3.30 | 4.59 | |
| Current Ratio | 2.74 | 2.74 | 2.08 | 3.47 | 3.42 | 4.70 | |
| Return on Equity (ROE) | -57.80% | -57.80% | -246.75% | -308.90% | -192.18% | -84.66% | |
| Return on Assets (ROA) | -6.55% | -6.55% | -23.15% | -32.22% | -27.58% | -18.01% | |
| Return on Capital Employed (ROCE) | -14.10% | -14.10% | -65.10% | -61.70% | -60.30% | -30.60% | |
| Earnings Yield | -0.96% | -0.75% | -21.21% | -16.49% | -20.64% | -9.48% | |
| FCF Yield | 1.41% | 1.10% | -15.66% | -41.45% | -13.80% | -1.05% | |
| Buyback Yield / Dilution | -13.09% | -13.08% | -6.22% | -16.48% | -6.56% | -25.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.